MedTrace Logo

Atlas Knee System Clinical System Clinical Study (USA)

NCT02934659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-05-09

No results posted yet for this study

Summary

The primary objective of this pilot study is to collect data on the safety and effectiveness of the Atlas Knee System in subjects with medial knee osteoarthritis through 24 months postoperative follow-up.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

Atlas(TM) Knee System

The Atlas System is an extra-capsular knee implant designed to unload the medial knee.

Sponsors & Collaborators

  • Moximed

    lead INDUSTRY

Principal Investigators

  • Rose Weinstein · Moximed

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-07-09
Completion
2023-05-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02934659 on ClinicalTrials.gov